載入...
Novel strategies to target proprotein convertase subtilisin kexin 9: beyond monoclonal antibodies
Since the discovery of the role of proprotein convertase subtilisin kexin 9 (PCSK9) in the regulation of low-density lipoprotein cholesterol (LDL-C) in 2003, a paradigm shift in the treatment of hypercholesterolaemia has occurred. The PCSK9 secreted into the circulation is a major downregulator of t...
Na minha lista:
| 發表在: | Cardiovasc Res |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6383053/ https://ncbi.nlm.nih.gov/pubmed/30629143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvz003 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|